ELIZABETA DE LOS ÁNGELES ROJAS RICARDO-rekin lankidetzan egindako argitalpenak (8)

2022

  1. Expression of p53 protein isoforms predicts survival in patients with multiple myeloma

    American Journal of Hematology, Vol. 97, Núm. 6, pp. 700-710

2020

  1. Effect of graphene family materials on multiple myeloma and non-Hodgkin's lymphoma cell lines

    Materials, Vol. 13, Núm. 15, pp. 1-21

2019

  1. Factors regulating microRNA expression and function in multiple myeloma

    Non-coding RNA, Vol. 5, Núm. 1

  2. Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background

    Blood Cancer Journal, Vol. 9, Núm. 12

2018

  1. A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: Biological and clinical utility

    Haematologica, Vol. 103, Núm. 5, pp. 880-889

2017

  1. Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma

    Clinical Cancer Research, Vol. 23, Núm. 21, pp. 6602-6615

2016

  1. Molecular mechanisms of p53 deregulation in cancer: An overview in multiple myeloma

    International Journal of Molecular Sciences, Vol. 17, Núm. 12

  2. Post-transcriptional modifications contribute to the upregulation of cyclin D2 in multiple myeloma

    Clinical Cancer Research, Vol. 22, Núm. 1, pp. 207-217